HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Palliative Care and Supportive Oncology
Palliative Care and Supportive Oncology
- Symptom Management: Pain, nausea, fatigue, and other common symptoms.
- Psychosocial Oncology: Addressing the emotional and mental health needs of patients.
- End-of-Life Care: Hospice care, ethical issues, and patient-family communication.
- Integrative Oncology: Use of complementary therapies alongside conventional treatments.
Palliative care in cancer treatment prioritizes enhancing the quality of life for patients by addressing their physical, emotional, and psychological challenges, especially in advanced stages. It focuses on alleviating symptoms and managing pain while offering vital support to both patients and families. Supportive oncology expands on this by focusing on treatments that help patients manage side effects from cancer therapies like chemotherapy and radiation. Combining palliative care with supportive oncology ensures a holistic approach to cancer treatment, focusing not only on symptom relief but also on emotional well-being, providing compassionate care throughout the treatment process.
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States CIOC 2026 Speakers
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China